News About: Pharm. Industry
Civic group calls for scrap hospital incentive system
The Citizens’ Coalition for Economic Justice said on December 21 that The government needs to scrap its plan to encourage hospitals to purchase low-priced medicines via incentives, adding rebate activities could be co...
Yuhan, UCB Korea to cooperate
Yuhan Corporation signed an exclusive distribution agreement with UCB Korea, a Korean unit of UCB Pharma Inc., headquartered in Belgium, it was leaned on December 21.
Under the agreement, Yuhan will be able to make...
Hanmi to market bone transplant materials
Hami Pharm said on December 21 that it has marketed SureFuse and ExFuse, bone transplant products developed by Hans Biomed, a local medical provider.
SureFuse and ExFuse are the mixtures of DBM (Demineralized Bone ...
FTC not considering easing of anti-rebate rules
The Free Trade Commission (FTC) is not considering easing overseas academic meetings to be promoted by multinational pharmaceutical companies.
To this end, Korea’s antitrust regulator was said to hold a Dec. 18 mee...
Handok, Sanofi Pateur to cooperate in vaccine business
In an effort to ensure an stable supply of the vaccine in Korea, Korea's Handok Pharm has joined hands with the French vaccine maker Sanofi Pasteur SA to distribute vaccine products produced by Sanofi Pasteur from Jan...
Low-priced incentive system will hurt pharmaceutical sector
Pharmaceutical business sources say Korea's pharmaceutical sector could lose a tremendous loss if the government’s plan to promote local hospitals to purchase low-priced medicines via a certain portion of incentive to...
Drug makers, pharmacists discuss small packet of drugs
The Korea Pharmaceutical Manufacturers Association and pharmacists agreed to exchange information over the efficient supply of small packet of drugs, the Korea Food and Drug Administration said on December 17.
To t...
General Electric to set up global health center in Incheon FEZ
General Electric plans to set up a global u-health R&D center in Songdo, a site of Incheon Free Economic Zone, in 2010.
GE Healthcare, a medical development and investment unit of the global company, signed a joint...
Boehringer Ingelheim releases ambroxol HCl tablets
Boehringer Ingelheim Korea said it has launched Mucoangin (ambroxol HCl), a troche-type mucolytic agent used in the treatment of respiratory disorders associated with viscid or excessive mucus.
The substance is a m...
FTC to probe KRPIA proposal
Korea’s antitrust regulator will embark on looking into the revision of a fair trade agreement, such as promotional meetings held at the headquarters of foreign pharmaceutical companies.
The Fair Trade Commission (...
